{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:47:08Z","timestamp":1791985628159,"version":"4.4.0"},"reference-count":29,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypoxia-inducible lipid droplet-associated protein (HILPDA) promotes hepatic lipid accumulation. Hilpda gene expression is directly regulated by hypoxia-inducible factors (HIF1A and HIF1B) and the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR\u03b1). However, whether the expression of Hilpda is regulated by peroxisome proliferator-activated receptor gamma (PPAR\u03b3) in fatty liver remains unclear. In this study, we investigated the role of PPAR\u03b3 in regulating Hilpda expression in fatty liver. Analysis of publicly available microarray datasets revealed that Hilpda expression is significantly increased in the fatty liver of patients with metabolic dysfunction-associated steatotic liver disease, as well as in obese and type 2 diabetes model ob\/ob mice, high-fat diet-fed mice, and mice fed a high-fat, cholesterol-, and fructose-enriched diet, all of which exhibit elevated PPAR\u03b3 expression. In contrast, Ppara\/PPARA expression in the liver remained unchanged in mouse fatty liver models and was decreased in human MASLD liver samples. Hilpda expression in the fatty liver of ob\/ob mice was further induced by PPAR\u03b3 ligand treatment; however, this induction was significantly repressed in liver-specific PPAR\u03b3-deficient mice. Complementary in vitro analyses showed that ectopic expression and ligand activation of PPAR\u03b3 in liver-derived AML-12 cells were sufficient to induce Hilpda transcription, whereas Hif1a and Hif1b were only modestly induced, indicating a minimal contribution of HIF-1 signaling. Overall, our study identifies Hilpda as a key component of the liver PPAR\u03b3-driven gene network, highlighting its role as a metabolic effector that adapts to pathological lipid accumulation.<\/jats:p>","DOI":"10.1530\/jme-26-0006","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:07:06Z","timestamp":1790780826000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-6","source":"Crossref","is-referenced-by-count":0,"title":["<i>Hilpda<\/i>\n                    gene expression in steatotic liver is regulated by peroxisome proliferator-activated receptor \u03b3"],"prefix":"10.1530","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3437-1531","authenticated-orcid":true,"given":"Daisuke","family":"Aibara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Matsusue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026101409014542000_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature"},{"key":"2026101409014542000_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2026101409014542000_bib3","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101409014542000_bib4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Skat-R\u00f8rdam","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026101409014542000_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res"},{"key":"2026101409014542000_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J Pathol"},{"key":"2026101409014542000_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol Cell"},{"key":"2026101409014542000_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"Matsusue","year":"2003","journal-title":"J Clin Investig"},{"key":"2026101409014542000_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmet.2008.03.003","article-title":"Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27","volume":"7","author":"Matsusue","year":"2008","journal-title":"Cell Metab"},{"key":"2026101409014542000_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1507\/endocrj.EJ19-0296","article-title":"Fat-specific protein 27b is regulated by hepatic peroxisome proliferator-activated receptor \u03b3 in hepatic steatosis","volume":"67","author":"Aibara","year":"2020","journal-title":"Endocr J"},{"key":"2026101409014542000_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.111887","article-title":"Oxysterol-binding protein-like 3 is a novel target gene of peroxisome proliferator-activated receptor \u03b3 in fatty liver disease","volume":"565","author":"Aibara","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"2026101409014542000_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/gtc.13052","article-title":"Transcriptional regulation of adipogenin expression in liver steatosis by hepatic peroxisome proliferator-activated receptor gamma","volume":"28","author":"Aibara","year":"2023","journal-title":"Genes Cells"},{"key":"2026101409014542000_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111678","article-title":"Glycoprotein nonmetastatic melanoma protein B is regulated by hepatic peroxisome proliferator-activated receptor \u03b3 in liver steatosis","volume":"130","author":"Aibara","year":"2025","journal-title":"Cell Signal"},{"key":"2026101409014542000_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/hep.27573","article-title":"FSP27\u03b2, a novel fat-specific protein 27 isoform promoting hepatic steatosis","volume":"61","author":"Puri","year":"2015","journal-title":"Hepatology"},{"key":"2026101409014542000_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI85499","article-title":"Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease","volume":"127","author":"Stein","year":"2017","journal-title":"J Clin Investig"},{"key":"2026101409014542000_bib16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s42255-019-0065-4","article-title":"Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance","volume":"1","author":"Gong","year":"2019","journal-title":"Nat Metab"},{"key":"2026101409014542000_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108810","article-title":"Phenotypic characterization of Adig null mice suggests roles for adipogenin in the regulation of fat mass accrual and leptin secretion","volume":"34","author":"Alvarez-Guaita","year":"2021","journal-title":"Cell Rep"},{"key":"2026101409014542000_bib18","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1096\/fj.10-159806","article-title":"Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1","volume":"24","author":"Gimm","year":"2010","journal-title":"FASEB J"},{"key":"2026101409014542000_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101168","article-title":"Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes","volume":"47","author":"de la Rosa Rodriguez","year":"2021","journal-title":"Mol Metabol"},{"key":"2026101409014542000_bib20","doi-asserted-by":"crossref","first-page":"19279","DOI":"10.1074\/jbc.M114.570044","article-title":"Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion","volume":"289","author":"Mattijssen","year":"2014","journal-title":"J Biol Chem"},{"key":"2026101409014542000_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2023.03.041","article-title":"HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia","volume":"79","author":"Povero","year":"2023","journal-title":"J Hepatol"},{"key":"2026101409014542000_bib22","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1248\/bpb.b13-00351","article-title":"Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver","volume":"36","author":"Aibara","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"2026101409014542000_bib23","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2026101409014542000_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112379","article-title":"Transmembrane and coiled-coil domain family 3 gene is a novel target of hepatic peroxisome proliferator-activated receptor \u03b3 in fatty liver disease","volume":"594","author":"Aibara","year":"2024","journal-title":"Mol Cell Endocrinol"},{"key":"2026101409014542000_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2026.112456","article-title":"Small proline-rich protein 1A is a novel target of peroxisome proliferator-activated receptor gamma in steatotic liver disease","volume":"143","author":"Aibara","year":"2026","journal-title":"Cell Signal"},{"key":"2026101409014542000_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124544","article-title":"Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease","volume":"10","author":"Frades","year":"2015","journal-title":"PLoS One"},{"key":"2026101409014542000_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jcmgh.2021.01.003","article-title":"Hepatocyte-specific loss of PPAR\u03b3 protects mice from NASH and increases the therapeutic effects of rosiglitazone in the liver","volume":"11","author":"Lee","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026101409014542000_bib28","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2013.06.023","article-title":"Cell-specific PPAR\u03b3 deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells","volume":"59","author":"Mor\u00e1n-Salvador","year":"2013","journal-title":"J Hepatol"},{"key":"2026101409014542000_bib29","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1096\/fj.201700235R","article-title":"Hypoxia-inducible protein 2 Hig2\/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice","volume":"31","author":"Maier","year":"2017","journal-title":"FASEB J"}],"container-title":["Journal of Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article-pdf\/doi\/10.1530\/JME-26-0006\/525888\/jme-26-0006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article-pdf\/doi\/10.1530\/JME-26-0006\/525888\/jme-26-0006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:02:39Z","timestamp":1791982959000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/jme\/article\/77\/3\/e260006\/78287\/Hilpda-gene-expression-in-steatotic-liver-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/jme-26-0006","relation":{},"ISSN":["0952-5041","1479-6813"],"issn-type":[{"value":"0952-5041","type":"print"},{"value":"1479-6813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"e260006"}}